• Atossa Therapeutics, Breast Health

Surgeon General’s Breast Cancer Advisory Explained | Atossa Therapeutics Responds

The Surgeon General’s recent advisory highlights a critical but often overlooked truth: even light alcohol consumption can increase the risk of breast cancer. In this video, Dr. Steven Quay, CEO of Atossa Therapeutics, breaks down what this advisory means for public health and how it aligns with Atossa’s mission to prevent breast cancer before it starts.

With over 44,000 breast cancer cases linked to alcohol each year, understanding the risks—and spreading awareness—can make a lasting difference.

Watch the full video to learn more, and if you want the full details, you can read the official press release here: Official Press Release.

  • Tags: (Z)-Endoxifen Research, Alcohol and Cancer Risk, Alcohol Consumption Risks, Atossa Therapeutics, Biopharmaceutical Advancements, Breast Cancer Awareness, Breast cancer prevention, Breast cancer research, Cancer Prevention, Cancer Risk Factors, Dr. Steven Quay, Health Education, Oncology Innovations, Public Health Advisory, Surgeon General Cancer Advisory, Women’s Health

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content

CVille Right Now: Dr. Steven Quay on the Surprising Link Between Alcohol and Cancer

January 7, 2025

A Conversation on Public Health Reform with Dr. Steven Quay

December 17, 2024

Atossa Therapeutics Reports Positive KARISMA-Endoxifen Results: Endoxifen Reduces Breast Density

November 8, 2024

(Z)-Endoxifen Shown to Significantly Reduce Mammographic Breast Density, Potentially Paving the Way for Innovative Cancer Prevention Strategies

Join Dr. Quay’s ElevatorMedicine™ and get FREE, QUICK TIPS for better living, health, and wellness that take less time than riding an elevator!